JP5141919B2 - 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム - Google Patents
細胞処理デバイス、細胞処理カートリッジおよび体液処理システム Download PDFInfo
- Publication number
- JP5141919B2 JP5141919B2 JP2009206623A JP2009206623A JP5141919B2 JP 5141919 B2 JP5141919 B2 JP 5141919B2 JP 2009206623 A JP2009206623 A JP 2009206623A JP 2009206623 A JP2009206623 A JP 2009206623A JP 5141919 B2 JP5141919 B2 JP 5141919B2
- Authority
- JP
- Japan
- Prior art keywords
- cell
- tapered portion
- slit member
- cancer cells
- treatment device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011282 treatment Methods 0.000 title claims description 170
- 210000001124 body fluid Anatomy 0.000 title claims description 29
- 239000010839 body fluid Substances 0.000 title claims description 26
- 210000004027 cell Anatomy 0.000 claims description 492
- 201000011510 cancer Diseases 0.000 claims description 194
- 206010028980 Neoplasm Diseases 0.000 claims description 193
- 239000006185 dispersion Substances 0.000 claims description 119
- 210000002865 immune cell Anatomy 0.000 claims description 54
- 230000009471 action Effects 0.000 claims description 47
- 239000007788 liquid Substances 0.000 claims description 45
- 230000002441 reversible effect Effects 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 30
- 230000000704 physical effect Effects 0.000 claims description 27
- 238000012545 processing Methods 0.000 claims description 15
- 230000000975 bioactive effect Effects 0.000 claims description 12
- 230000007423 decrease Effects 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 230000000149 penetrating effect Effects 0.000 claims description 8
- 230000000903 blocking effect Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 description 39
- 108090000695 Cytokines Proteins 0.000 description 39
- 238000000034 method Methods 0.000 description 36
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 239000003446 ligand Substances 0.000 description 26
- 239000000463 material Substances 0.000 description 20
- 238000010586 diagram Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 14
- 230000001640 apoptogenic effect Effects 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 11
- 239000012190 activator Substances 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000013545 self-assembled monolayer Substances 0.000 description 9
- 230000001766 physiological effect Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 239000002094 self assembled monolayer Substances 0.000 description 8
- 230000006907 apoptotic process Effects 0.000 description 7
- 230000003100 immobilizing effect Effects 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 239000000560 biocompatible material Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 206010027476 Metastases Diseases 0.000 description 4
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000009401 metastasis Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 3
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 206010028851 Necrosis Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 102100040247 Tumor necrosis factor Human genes 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000013462 Interleukin-12 Human genes 0.000 description 2
- 108010065805 Interleukin-12 Proteins 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 239000004695 Polyether sulfone Substances 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 102000006815 folate receptor Human genes 0.000 description 2
- 108020005243 folate receptor Proteins 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 229940117681 interleukin-12 Drugs 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920006393 polyether sulfone Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 239000004627 regenerated cellulose Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- UUBHZHZSIKRVIV-KCXSXWJSSA-N (2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,4,6,10,14-pentaenoic acid Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(\C)=C\C(O)=O UUBHZHZSIKRVIV-KCXSXWJSSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 102000011690 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102100022002 CD59 glycoprotein Human genes 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 108010039471 Fas Ligand Protein Proteins 0.000 description 1
- 102000015212 Fas Ligand Protein Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
- 102400001240 Inter-alpha-trypsin inhibitor light chain Human genes 0.000 description 1
- 101800001691 Inter-alpha-trypsin inhibitor light chain Proteins 0.000 description 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 108050000637 N-cadherin Proteins 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
- 108700012411 TNFSF10 Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940022399 cancer vaccine Drugs 0.000 description 1
- 238000009566 cancer vaccine Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- AXTNPHLCOKUMDY-UHFFFAOYSA-N chromium cobalt Chemical compound [Co][Cr][Co] AXTNPHLCOKUMDY-UHFFFAOYSA-N 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 238000009751 slip forming Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009206623A JP5141919B2 (ja) | 2009-09-08 | 2009-09-08 | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009206623A JP5141919B2 (ja) | 2009-09-08 | 2009-09-08 | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009078455A Division JP4849278B2 (ja) | 2009-03-27 | 2009-03-27 | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010227087A JP2010227087A (ja) | 2010-10-14 |
| JP2010227087A5 JP2010227087A5 (https=) | 2012-04-05 |
| JP5141919B2 true JP5141919B2 (ja) | 2013-02-13 |
Family
ID=43043634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009206623A Active JP5141919B2 (ja) | 2009-09-08 | 2009-09-08 | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5141919B2 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3072578A1 (en) | 2015-03-23 | 2016-09-28 | ARKRAY, Inc. | Method for isolating or detecting rare cell |
| US11033900B2 (en) | 2015-03-23 | 2021-06-15 | Arkray, Inc. | Method for isolating or detecting rare cell |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5870323B2 (ja) * | 2011-05-23 | 2016-02-24 | 国立大学法人名古屋大学 | がん細胞自動分離装置およびがん細胞自動分離方法 |
| JP5929915B2 (ja) * | 2011-08-18 | 2016-06-08 | コニカミノルタ株式会社 | 細胞平面展開デバイスおよびこれを用いた細胞展開方法 |
| CN104640971B (zh) * | 2012-09-19 | 2017-03-15 | 国立研究开发法人科学技术振兴机构 | 神经细胞网络的形成及其利用、以及神经细胞播种器件 |
| JPWO2017061528A1 (ja) * | 2015-10-09 | 2018-07-26 | 国立大学法人名古屋大学 | 血小板製造用デバイス、血小板製造装置及び血小板製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004042012A (ja) * | 2001-10-26 | 2004-02-12 | Nec Corp | 分離装置、分析システム、分離方法および分離装置の製造方法 |
| US8173413B2 (en) * | 2005-08-11 | 2012-05-08 | University Of Washington | Separation and concentration of biological cells and biological particles using a one-dimensional channel |
-
2009
- 2009-09-08 JP JP2009206623A patent/JP5141919B2/ja active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3072578A1 (en) | 2015-03-23 | 2016-09-28 | ARKRAY, Inc. | Method for isolating or detecting rare cell |
| US11033900B2 (en) | 2015-03-23 | 2021-06-15 | Arkray, Inc. | Method for isolating or detecting rare cell |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010227087A (ja) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4849278B2 (ja) | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム | |
| JP2010227012A (ja) | がん細胞捕捉デバイス | |
| JP5141919B2 (ja) | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム | |
| Fromen et al. | Neutrophil–particle interactions in blood circulation drive particle clearance and alter neutrophil responses in acute inflammation | |
| Kim et al. | Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo | |
| JP2019527536A (ja) | バイオプロセシングのための音響分離 | |
| US10258734B2 (en) | Devices, systems and methods for cell modification | |
| US20080102030A1 (en) | Particles for cell targeting | |
| JP2010227014A (ja) | 細胞捕捉デバイスおよび細胞捕捉システム | |
| Shafaei et al. | The immune-stealth polymeric coating on drug delivery nanocarriers: In vitro engineering and in vivo fate | |
| Yang et al. | Tumor-derived microvesicles for cancer therapy | |
| DE102015120099B4 (de) | Ultraschallsonde zur Detektion von Fremdstrukturen in Fluiden | |
| JP2010227013A (ja) | 細胞捕捉デバイスおよび細胞捕捉システム | |
| TWI721352B (zh) | 含有gm3神經節苷酯作為免疫調節劑之奈米粒子 | |
| US20080206344A1 (en) | Endocytotic particles | |
| US20100029785A1 (en) | Particle compositions with a pre-selected cell internalization mode | |
| Yuan et al. | Origin, metastasis, harm, recognition and capture, and elimination of circulating tumor cells | |
| Miller et al. | In vitro clumping of platelets exposed to low intensity ultrasound | |
| EP3369804A1 (en) | Cell-spreading method and cell-spreading kit for observing rare cells | |
| EP2326314A1 (en) | Particle compositions with a pre-selected cell internalization mode | |
| Arpinati et al. | Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of Neutrophils. Cancers 2021, 13, 5082 | |
| CN121713062A (zh) | 处理循环细胞簇 | |
| Empsen et al. | 1.4 Sinusoidal liver cells | |
| WO2025122575A1 (en) | Treatment for disease modification | |
| Wang et al. | Toll-like Receptor 4 Antagonist Restores Vulnerability of Drug-Tolerant Tumor Cells and Prevents Breast Cancer Metastasis and Post-Surgical Relapse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120221 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120221 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121015 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121024 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121106 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151130 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5141919 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |